| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |